What does E4MEDICAL do?

E4MEDICAL is an events organiser in Brugge. Private Limited, started on 10 November 2015, 1 establishment.

What is the address of E4MEDICAL?

The registered office of E4MEDICAL is located at Augustijnenrei 15 box 202, 8000 Brugge.

Is E4MEDICAL still active?

Yes. According to the CBE (30 October 2026) E4MEDICAL is active, legal situation “Normale toestand”, started on 10 November 2015.

Is E4MEDICAL registered on Peppol?

Yes, E4MEDICAL is registered on the Peppol network with ID 0208:0642799402.

What is the enterprise number of E4MEDICAL?

The enterprise number of E4MEDICAL is BE0642799402.

When was E4MEDICAL founded?

E4MEDICAL was founded on 10 November 2015.

Who are the directors of E4MEDICAL?

According to the 2025 annual accounts, the directors of E4MEDICAL are: Alexandros EPIFANIS.

Is E4MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 November 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did E4MEDICAL make in 2025?

E4MEDICAL posted a profit after taxes of € 294,277 in financial year 2025.

What is the revenue of E4MEDICAL?

As a small company, E4MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 393,520.

E4MEDICAL (Private Limited) - Brugge - BE0642799402

Dossier E4MEDICAL, printed on 30 October 2026 from databakkes.be/en/0642799402/e4medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

E4MEDICAL from Brugge, company number BE0642799402, closed financial year 2025 with a result of € 294,277 after tax. For that financial year E4MEDICAL recorded a gross margin of € 393,520 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 193,127 to € 294,277. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Growing

€ 1.2 million

▲ 19% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 294,277

▲ 52% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 647,566

▼ 17% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

34 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 213,017

▲ 129% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,443

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 341,630 Gross margin 2022: € 341,630 First fiscal year in the series	€ 478,952 Gross margin 2023: € 478,952 ▲ 40% vs 2022 (€ 341,630) Favourable step	€ 251,873 Gross margin 2024: € 251,873 ▼ 47% vs 2023 (€ 478,952) Unfavourable step	€ 393,520 Gross margin 2025: € 393,520 ▲ 56% vs 2024 (€ 251,873) Favourable step	▲ 56%
Profit after taxes	€ 253,496 Profit after taxes 2022: € 253,496 First fiscal year in the series	€ 352,015 Profit after taxes 2023: € 352,015 ▲ 39% vs 2022 (€ 253,496) Favourable step	€ 193,127 Profit after taxes 2024: € 193,127 ▼ 45% vs 2023 (€ 352,015) Unfavourable step	€ 294,277 Profit after taxes 2025: € 294,277 ▲ 52% vs 2024 (€ 193,127) Favourable step	▲ 52%
Equity	€ 455,652 Equity 2022: € 455,652 First fiscal year in the series	€ 807,667 Equity 2023: € 807,667 ▲ 77% vs 2022 (€ 455,652) Favourable step	€ 1,000,794 Equity 2024: € 1,000,794 ▲ 24% vs 2023 (€ 807,667) Favourable step	€ 1,195,071 Equity 2025: € 1,195,071 ▲ 19% vs 2024 (€ 1,000,794) Favourable step	▲ 19%
Total debts	€ 222,853 Total debts 2022: € 222,853 First fiscal year in the series	€ 284,744 Total debts 2023: € 284,744 ▲ 28% vs 2022 (€ 222,853) Unfavourable step	€ 132,556 Total debts 2024: € 132,556 ▼ 53% vs 2023 (€ 284,744) Favourable step	€ 221,461 Total debts 2025: € 221,461 ▲ 67% vs 2024 (€ 132,556) Unfavourable step	▲ 67%
Cash	€ 336,511 Cash 2022: € 336,511 First fiscal year in the series	€ 578,921 Cash 2023: € 578,921 ▲ 72% vs 2022 (€ 336,511) Favourable step	€ 779,985 Cash 2024: € 779,985 ▲ 35% vs 2023 (€ 578,921) Favourable step	€ 647,566 Cash 2025: € 647,566 ▼ 17% vs 2024 (€ 779,985) Unfavourable step	▼ 17%
Retained profit	€ 443,152 Retained profit 2022: € 443,152 First fiscal year in the series	€ 795,167 Retained profit 2023: € 795,167 ▲ 79% vs 2022 (€ 443,152) Favourable step	€ 988,294 Retained profit 2024: € 988,294 ▲ 24% vs 2023 (€ 795,167) Favourable step	€ 1,182,571 Retained profit 2025: € 1,182,571 ▲ 20% vs 2024 (€ 988,294) Favourable step	▲ 20%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 100,000 Dividend 2025: € 100,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 678,505 Balance sheet total 2022: € 678,505 First fiscal year in the series	€ 1,092,412 Balance sheet total 2023: € 1,092,412 ▲ 61% vs 2022 (€ 678,505) Unchanged	€ 1,133,350 Balance sheet total 2024: € 1,133,350 ▲ 4% vs 2023 (€ 1,092,412) Unchanged	€ 1,416,532 Balance sheet total 2025: € 1,416,532 ▲ 25% vs 2024 (€ 1,133,350) Unchanged	▲ 25%

Key figures of E4MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to E4MEDICAL?

What happened at E4MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 29, 2026 New annual accounts for financial year 2025: profit of € 294,277 (▲ 52% vs 2024). Source: NBB ↗
Nov 10, 2015 New establishment in Brugge. KBO
2015 Alexandros EPIFANIS became a director. NBB
Nov 10, 2015 Start of the company according to the CBE. KBO

In short

From € 253,496 profit in 2022 to € 294,277 profit in 2025.

Paid € 364,772 in corporate taxes since 2022.

Best year ever: 2023, with € 352,015 profit.

Paid out € 100,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Alexandros EPIFANIS

E4MEDICAL

Behind E4MEDICAL is Alexandros EPIFANIS.

Directors

According to the 2025 annual accounts

Alexandros EPIFANIS

Director

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Augustijnenrei 15 box 202

8000 Brugge

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

RED MORPHO

€ -30,822 gross margin · 2025

FRANGIPANI

€ 132,219 gross margin · 2025

België Beheer

CREME DE LA CREME

€ -8,757 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0642.799.402

VAT number

BE 0642.799.402

Registered office

Augustijnenrei 15 bus 202, 8000 Brugge

Names & denominations

E4MEDICAL

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

10 November 2015

Peppol

Active · Active since 19 Dec 2025

Activities · NACE

Organisatie van congressen en beurzen

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige zakelijke dienstverlening, neg

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

E4MEDICAL

Financials

What happened to E4MEDICAL?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions